DE69232579T2 - Anti-Plättchen-Wachstumsfaktor-Antikörper in der Behandlung von Restenose - Google Patents

Anti-Plättchen-Wachstumsfaktor-Antikörper in der Behandlung von Restenose

Info

Publication number
DE69232579T2
DE69232579T2 DE69232579T DE69232579T DE69232579T2 DE 69232579 T2 DE69232579 T2 DE 69232579T2 DE 69232579 T DE69232579 T DE 69232579T DE 69232579 T DE69232579 T DE 69232579T DE 69232579 T2 DE69232579 T2 DE 69232579T2
Authority
DE
Germany
Prior art keywords
growth factor
restenosis
treatment
factor antibody
platelet growth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69232579T
Other languages
English (en)
Other versions
DE69232579D1 (de
Inventor
Russell Ross
Michael A Reidy
Elaine W Raines
Volkhard Lindner
Gordon A A Ferns
Christopher Jackson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Washington
Original Assignee
University of Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Washington filed Critical University of Washington
Publication of DE69232579D1 publication Critical patent/DE69232579D1/de
Application granted granted Critical
Publication of DE69232579T2 publication Critical patent/DE69232579T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69232579T 1991-01-17 1992-01-17 Anti-Plättchen-Wachstumsfaktor-Antikörper in der Behandlung von Restenose Expired - Fee Related DE69232579T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US64175891A 1991-01-17 1991-01-17

Publications (2)

Publication Number Publication Date
DE69232579D1 DE69232579D1 (de) 2002-05-29
DE69232579T2 true DE69232579T2 (de) 2002-08-22

Family

ID=24573729

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69224983T Expired - Fee Related DE69224983T2 (de) 1991-01-17 1992-01-17 Anti-wachstumsfaktor antikörper in der behandlung von gefässstenose
DE69232579T Expired - Fee Related DE69232579T2 (de) 1991-01-17 1992-01-17 Anti-Plättchen-Wachstumsfaktor-Antikörper in der Behandlung von Restenose

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE69224983T Expired - Fee Related DE69224983T2 (de) 1991-01-17 1992-01-17 Anti-wachstumsfaktor antikörper in der behandlung von gefässstenose

Country Status (10)

Country Link
US (1) US5648076A (de)
EP (2) EP0798002B1 (de)
JP (2) JP3667752B2 (de)
AT (2) ATE164521T1 (de)
AU (1) AU665529B2 (de)
CA (1) CA2100876A1 (de)
DE (2) DE69224983T2 (de)
DK (2) DK0573510T3 (de)
ES (2) ES2174144T3 (de)
WO (1) WO1992012734A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5770198A (en) * 1988-05-18 1998-06-23 The Research Foundation Of The State Of New York Platelet-specific chimeric 7E3 immunoglobulin
EP0835135A2 (de) * 1995-06-07 1998-04-15 Centocor, Inc. Plättchen-spezifisches, chimäres immunglobulin und verfahren zu seiner verwendung
US7241568B2 (en) 1996-04-03 2007-07-10 Kyowa Hakko Kogyo Co., Ltd. Anti-fibroblast growth factor-8 monoclonal antibody
WO1998035697A1 (en) * 1997-02-14 1998-08-20 Roche Diagnostics Gmbh Improved method for the reduction of neointima formation after angioplasty
CA2451854A1 (en) * 2001-06-28 2003-01-09 Kyowa Hakko Kogyo Co., Ltd. Humanized antibody against fibroblast growth factor-8 and antibody fragment thereof
PT1680140E (pt) * 2003-10-16 2011-05-31 Imclone Llc Inibidores do receptor-1 do factor de crescimento de fibroblastos e m?todos de tratamento destes
US9339593B2 (en) * 2007-01-11 2016-05-17 Robert L. Bjork, JR. Drug-eluting coronary artery stent coated with anti-platelet-derived growth factor antibodies overlaying extracellular matrix proteins with an outer coating of anti-inflammatory (calcineurin inhibitor) and/or anti-proliferatives
WO2008086490A2 (en) * 2007-01-11 2008-07-17 Robert Lamar Bjork, Jr Multiple drug-eluting coronary artery stent for percutaneous coronary artery intervention
WO2016149103A1 (en) * 2015-03-13 2016-09-22 The Regents Of The University Of California Monoclonal antibody for prevention and/or treatment of astrovirus disease

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE116373T1 (de) * 1987-03-03 1995-01-15 Takeda Chemical Industries Ltd Monoklonaler antikörper, hybridomen, ihre herstellung und ihre verwendung.
AU607306B2 (en) * 1988-02-02 1991-02-28 Regents Of The University Of California, The Human platelet-derived growth factor receptor
US5268358A (en) * 1988-12-08 1993-12-07 Cor Therapeutics, Inc. PDGF receptor blocking peptides
AU6605690A (en) * 1989-10-27 1991-05-31 Du Pont Merck Pharmaceutical Company, The Monoclonal antibodies to basic fibroblast growth factor that inhibit its biological activity
JP4350370B2 (ja) * 2002-12-27 2009-10-21 株式会社半導体エネルギー研究所 電子回路及び電子機器

Also Published As

Publication number Publication date
CA2100876A1 (en) 1992-07-18
JPH06504551A (ja) 1994-05-26
DE69224983D1 (de) 1998-05-07
DE69232579D1 (de) 2002-05-29
ES2174144T3 (es) 2002-11-01
ATE164521T1 (de) 1998-04-15
US5648076A (en) 1997-07-15
EP0798002A1 (de) 1997-10-01
AU1327492A (en) 1992-08-27
DE69224983T2 (de) 1998-07-30
ES2117046T3 (es) 1998-08-01
JP3667752B2 (ja) 2005-07-06
AU665529B2 (en) 1996-01-11
EP0573510A1 (de) 1993-12-15
ATE216592T1 (de) 2002-05-15
JP2002316945A (ja) 2002-10-31
WO1992012734A1 (en) 1992-08-06
EP0798002B1 (de) 2002-04-24
DK0798002T3 (da) 2002-08-19
DK0573510T3 (da) 1998-04-27
EP0573510B1 (de) 1998-04-01

Similar Documents

Publication Publication Date Title
DE69224080D1 (de) Verwendung von nsaid zur behandlung von demenz
DE69220355D1 (de) Selbstausspreizbare, vaskuläre Endoprothese
DE4396657T1 (de) Gefäßprothese
DE69229539T2 (de) Okklusionsvorrichtung zur Reparatur von Herz- und Gefäss-Defekten
DK189886D0 (da) Roerformet proteseartikel
SE8803472D0 (sv) Anvaendning av gamma-interferon foer behandling av vaskulaer stenos
DE69232579D1 (de) Anti-Plättchen-Wachstumsfaktor-Antikörper in der Behandlung von Restenose
DE69109583D1 (de) Verfahren zur Behandlung von entzündlichen Darmerkrankungen.
DE69130586T2 (de) Behandlung von Pankreaskrankheit mit 15-keto-Prostaglandin E-Derivaten
DE59200773D1 (de) Arzneimittel zur Behandlung von Abstossungsreaktionen bei Organverpflanzungen.
AU6178094A (en) Polyurethane-coated intravascular prostheses (stents) for the treatment of blood vessel stenosis
DK452089A (da) Anvendelse af ace-inhibitorer
NO913117L (no) Fremgangsmaate for behandling av benoedeleggende sykdommer.
DK0661981T3 (da) Anvendelse af hyaluronsyre og derivater heraf til forebyggelse mod arteriel restenose
NO924637D0 (no) Fremgangsmaate ved forhindring av gjentilstopping av arterier
ATE129895T1 (de) Behandlung von pulmonarer disfunktion mit 15-keto-prostaglandin-derivaten.
DE69412178D1 (de) Apparat zur Behandlung von Lagen
FR2669539B1 (fr) Dispositif pour la circulation artificielle du sang et transfuseur autologue de sang total.
UA10928C2 (uk) Спосіб профілактики гіперхолестериhемії
IT8867135A0 (it) Protesi ad espansione endoluminale particolarmente per il trattamentodi patologie vascolari
Kornhauser et al. Light-induced dermal toxicity: Effects on the cellular and molecular levels.
DK417889D0 (da) Anvendelse af 2-azabicyklo(2.2.2.)-carboxylsyrederivater til fremstilling af medicinske produkter til behandling af vaskulaere sygdomme
NO905643D0 (no) Fremgangsmaate for behandling av manganslam.
ATE86857T1 (de) Transdermate magensafthemmende wirkstoffe zur behandlung von magen-darm-erkrankungen.
KR920010021A (ko) 알루미늄-구리-실리콘(Al-Cu-Si)합금의 표면 처리 방법

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee